Commonwealth Equity Services’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $268K | Buy |
20,607
+3,638
| +21% | +$47.3K | ﹤0.01% | 3695 |
|
|
2025
Q1 | $180K | Buy |
16,969
+353
| +2% | +$3.74K | ﹤0.01% | 3870 |
|
|
2024
Q4 | $282K | Sell |
16,616
-2,039
| -11% | -$34.6K | ﹤0.01% | 3465 |
|
|
2024
Q3 | $433K | Buy |
18,655
+4,234
| +29% | +$98.3K | ﹤0.01% | 3010 |
|
|
2024
Q2 | $351K | Buy |
14,421
+328
| +2% | +$7.98K | ﹤0.01% | 3162 |
|
|
2024
Q1 | $476K | Buy |
14,093
+631
| +5% | +$21.3K | ﹤0.01% | 2858 |
|
|
2023
Q4 | $424K | Sell |
13,462
-1,277
| -9% | -$40.2K | ﹤0.01% | 2874 |
|
|
2023
Q3 | $377K | Buy |
14,739
+3,200
| +28% | +$81.9K | ﹤0.01% | 2830 |
|
|
2023
Q2 | $331K | Buy |
11,539
+1,100
| +11% | +$31.6K | ﹤0.01% | 2963 |
|
|
2023
Q1 | $250 | Buy |
10,439
+299
| +3% | +$7 | ﹤0.01% | 3118 |
|
|
2022
Q4 | $171K | Hold |
10,140
| – | – | ﹤0.01% | 3288 |
|
|
2022
Q3 | $150K | Sell |
10,140
-587
| -5% | -$8.68K | ﹤0.01% | 3282 |
|
|
2022
Q2 | $168K | Sell |
10,727
-25
| -0.2% | -$392 | ﹤0.01% | 3256 |
|
|
2022
Q1 | $289K | Sell |
10,752
-420
| -4% | -$11.3K | ﹤0.01% | 3003 |
|
|
2021
Q4 | $413K | Buy |
11,172
+218
| +2% | +$8.06K | ﹤0.01% | 2689 |
|
|
2021
Q3 | $523K | Sell |
10,954
-653
| -6% | -$31.2K | ﹤0.01% | 2442 |
|
|
2021
Q2 | $392K | Buy |
11,607
+1,758
| +18% | +$59.4K | ﹤0.01% | 2665 |
|
|
2021
Q1 | $406K | Buy |
9,849
+974
| +11% | +$40.2K | ﹤0.01% | 2487 |
|
|
2020
Q4 | $385K | Buy |
8,875
+3,479
| +64% | +$151K | ﹤0.01% | 2344 |
|
|
2020
Q3 | $231K | Buy |
5,396
+935
| +21% | +$40K | ﹤0.01% | 2589 |
|
|
2020
Q2 | $208K | Buy |
+4,461
| New | +$208K | ﹤0.01% | 2562 |
|